Project description:RNA extracted from tumor samples of 86 patients affected by MPM was analyzed on the nCounter system using a custom panel called MPM_C9073 (Nanostring Technologies).
Project description:RNA extracted from tumor biopsies of 44 patients affected by ALCL was analyzed on the nCounter system using a custom panel called VF_150921 (Nanostring Technologies).
Project description:Biopsies were stimulated with OKT3 16 hours, epidermis was separated from dermis, RNA was purified and nanostring analysis was performed on a custom panel of transcripts.
Project description:Buffy coat PBMC RNA expression was tested using a custom Nanostring probe panel, to identify general immune and glucocorticoid receptor-associated immune genes. ClinicalTrials.gov Identifier: NCT00824941
Project description:Gene-expression profiling from 31 cHL FFPE samples using the NanoString technology, with the PanCancer Immune Profiling Panel with 30 extra custom genes, up to 800 total genes
Project description:Development of a non-invasive, whole blood microarray gene expression signature that accurately distinguishes malignant from benign lung nodules detected by LDCT and the successful transition of that signature to a custom NanoString panel with no loss of accuracy.
Project description:HIV and Methamphetamine study - Translational Methamphetamine AIDS Research Center - Dopamine-regulated inflammatory biomarkers A digital transcript panel was custom-made based on Hs_NeuroPath_v1 (Nanostring) to accommodate dopamine-regulated inflammatory genes that were previously identified in vitro, and hypothesized to cluster HIV+ Methamphetamine users.
